About Pegcetacoplan
            
            Class: | Complement inhibitor  
Use: | Treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH)  
Adult dose: | Initial dose: 1 mg/kg administered as an intravenous infusion once weekly; Maintenance dose: 1 mg/kg administered as an intravenous infusion every 2 weeks  
Pediatric dose: | Safety and efficacy have not been established in pediatric patients  
Side effects: | Headache, diarrhea, nausea, fatigue, injection site reactions, and abdominal pain  
Contraindications: | Hype
         
        
            
                
                
                    
                        Drug Class
                    
                    Complement inhibitor
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH)
                 
                
                
                    
                        Storage Requirements
                    
                    Store in the refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. Protect from light.
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Swedish Orphan Biovitrum AB, SWEDEN
                    
                    
                    Package Size
                    20ml Vial
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 16094.94
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        Initial dose: 1 mg/kg administered as an intravenous infusion once weekly; Maintenance dose: 1 mg/kg administered as an intravenous infusion every 2 weeks
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy have not been established in pediatric patients
                    
                 
                
                
                    
                        Side Effects
                    
                    Headache, diarrhea, nausea, fatigue, injection site reactions, and abdominal pain
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to pegcetacoplan or any component of the formulation
         
        
        
            
                Important Warnings
            
            Risk of serious infections due to complement inhibition; monitor for signs of infection. Use caution in patients with a history of infections or those at increased risk for infections.
         
        
        
        
        
        
        
        
            
                Related Medicines in Same Category
            
            
                See also: Other Complement inhibitor medicines available in UAE pharmacies
            
            
            
                Avacopan
            
            
            
                Danicopan,Danicopan
            
            
         
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.